The Westminster Health Forum conference on cancer research and genomics in England, taking place on the morning of Thursday 7 January 2027, will focus primarily on the NHS. But the agenda it sets, spanning earlier diagnosis, genomic testing, clinical trials reform and health data governance, has direct implications for the private healthcare sector too. Independent hospitals, private diagnostics providers and specialist cancer centres are increasingly delivering care alongside, and in partnership with, the NHS, and the workforce implications of this agenda will be felt across both.
For those of us recruiting into private healthcare, the conference offers an early signal of where skills demand is heading, and where private providers have an opportunity to differentiate through the talent they bring in.
Earlier diagnosis creates a Private Sector opportunity
Sessions will examine the evidence from the NHS-Galleri Trial and other multi-cancer early detection approaches, alongside the capacity pressures facing NHS pathology, imaging and endoscopy services. Private providers have long played a role in supplementing NHS diagnostic capacity, and this looks set to continue as demand for earlier detection grows faster than NHS capacity can expand.
For private healthcare employers, this points to:
- Sustained demand for diagnostic imaging, pathology and endoscopy specialists able to work at pace
- Opportunities to attract NHS-trained professionals seeking more flexible or better-resourced private settings
- A growing need for staff comfortable working across NHS referral pathways and private care models
Genomic and personalised medicine expertise is in short supply
Discussion of the new NHS Genomic Medicine Service arrangements, whole-genome sequencing capacity and personalised treatment pathways highlights a workforce gap that extends well beyond the NHS. Private providers offering, or looking to offer, genomic testing and personalised oncology services will be competing for a limited pool of specialists in clinical genomics, bioinformatics and laboratory science.
Candidates with genomics experience, whether from NHS, academic or industry settings, are likely to find strong demand and genuine choice in where they work over the coming year. For employers, this makes early and proactive engagement with this talent pool increasingly important.
Trial reform widens the door for Private Sector research
New UK clinical trials regulations in force since April 2026, the Cancer Trials Accelerator Programme and the Rare Cancers Act 2026 are all designed to increase the speed, scale and inclusivity of cancer trials. Private hospital groups and specialist cancer centres running their own trial programmes, or partnering with pharmaceutical and life sciences companies, stand to benefit from a more streamlined regulatory environment.
This is likely to support continued hiring into clinical research roles within private healthcare settings, particularly where organisations can offer patients faster access to trials than NHS capacity currently allows.
Data Governance will shape Private-NHS collaboration
As the single patient record is placed on a statutory footing and the Health Data Research Service begins providing access to national datasets, questions of governance and public trust will increasingly affect how private providers collaborate with the NHS. Private organisations handling patient data, whether for diagnostics, trials or shared care pathways, will need people who understand both clinical data and the governance frameworks now taking shape.
What this means for your Private Healthcare career
For those working within a Private Healthcare career, experience across NHS and private settings, or specific expertise in genomics, diagnostics or trial delivery, will be increasingly valuable as private providers compete for a limited pool of specialist talent. This is a good moment to consider how your experience positions you for that shift.
For those hiring in this space, the direction of travel favours building teams with flexibility across diagnostics, genomics, trial delivery and data governance, and with genuine familiarity with how private and NHS pathways interact. Early engagement with talent who understand both worlds will be an advantage as the sector responds to the National Cancer Plan through 2026 and beyond.
Supporting your hiring objectives and your career growth
If you are hiring within private healthcare, our team can provide insight into the current market, candidate expectations and the challenges affecting hiring decisions.
Equally, if you are considering your next career move and want to understand how your experience or an offer compares with the wider market, we would be happy to have a confidential conversation. If you would like to explore where your experience could take your career, I would be happy to have that conversation.
